PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 1, 2025Current Medical Research and Opinion33 citations

The systemic immune inflammation index is a reliable and novel risk factor for metabolic dysfunction-associated fatty liver disease

View Full Paper
MKMehmet Ali KösekliGAGülali Aktaş

Key Points

Key points are not available for this paper at this time.

Abstract

These findings suggest that SII could serve as a useful, noninvasive marker for diagnosing and monitoring MAFLD, warranting further longitudinal studies to explore its role in disease progression and treatment response.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kösekli et al. (2025) studied this question.

synapsesocial.com/papers/69dd5f4380eea7d3f699c206https://doi.org/10.1080/03007995.2025.2463952
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic2021 · 72 citations
  2. 2Investigation of the Associations of Novel Inflammatory Biomarkers—Systemic Inflammatory Index (SII) and Systemic Inflammatory Response Index (SIRI)—With the Severity of Coronary Artery Disease and Acute Coronary Syndrome Occurrence2022 · 320 citations
  3. 3The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients2020 · 358 citations
  4. 4Metabolic Significance of Nonalcoholic Fatty Liver Disease in Nonobese, Nondiabetic Adults2004 · 435 citations
  5. 5Mean Platelet Volume and Red Cell distribution width in Hepatosteatosis2013 · 28 citations